Published in Am J Pathol on June 01, 2011
Staphylococcal superantigens in colonization and disease. Front Cell Infect Microbiol (2012) 1.15
Update on staphylococcal superantigen-induced signaling pathways and therapeutic interventions. Toxins (Basel) (2013) 1.03
Chronic exposure to staphylococcal superantigen elicits a systemic inflammatory disease mimicking lupus. J Immunol (2012) 0.94
Systemic inflammatory response elicited by superantigen destabilizes T regulatory cells, rendering them ineffective during toxic shock syndrome. J Immunol (2014) 0.87
Linezolid is superior to vancomycin in experimental pneumonia caused by Superantigen-Producing staphylococcus aureus in HLA class II transgenic mice. Antimicrob Agents Chemother (2012) 0.87
Chimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB. PLoS One (2011) 0.86
The impact of Staphylococcus aureus-associated molecular patterns on staphylococcal superantigen-induced toxic shock syndrome and pneumonia. Mediators Inflamm (2014) 0.83
Superantigens produced by catheter-associated Staphylococcus aureus elicit systemic inflammatory disease in the absence of bacteremia. J Leukoc Biol (2015) 0.81
Staphylococcal Superantigens Spark Host-Mediated Danger Signals. Front Immunol (2016) 0.78
Superantigen-Producing Staphylococcus aureus Elicits Systemic Immune Activation in a Murine Wound Colonization Model. Toxins (Basel) (2015) 0.75
Concomitant Disruption of CD4 and CD8 Genes Facilitates the Development of Double Negative αβ TCR(+) Peripheral T Cells That Respond Robustly to Staphylococcal Superantigen. J Immunol (2017) 0.75
Whole genome sequencing of meticillin-resistant Staphylococcus aureus. Lancet (2001) 18.55
Genome and virulence determinants of high virulence community-acquired MRSA. Lancet (2002) 14.64
Exotoxins of Staphylococcus aureus. Clin Microbiol Rev (2000) 7.35
Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc Natl Acad Sci U S A (1979) 6.77
Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med (1996) 5.25
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B: critical role of tumor necrosis factor. J Exp Med (1992) 4.31
Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology (2006) 3.52
Gram-positive toxic shock syndromes. Lancet Infect Dis (2009) 3.37
NF-kappa B activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol (2006) 3.15
Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group. Clin Infect Dis (1999) 2.69
Experimental hepatitis induced by D-galactosamine. Exp Mol Pathol (1968) 2.47
The bacterial superantigen and superantigen-like proteins. Immunol Rev (2008) 2.44
In vivo imaging of NF-kappa B activity. J Immunol (2002) 2.36
The structural basis of T cell activation by superantigens. Annu Rev Immunol (1999) 2.34
Humane endpoints in shock research. Shock (2004) 2.18
Epithelial barrier dysfunction: a unifying theme to explain the pathogenesis of multiple organ dysfunction at the cellular level. Crit Care Clin (2005) 1.95
NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity (2000) 1.91
Purification and physicochemical and biological characterization of a staphylococcal pyrogenic exotoxin. Infect Immun (1979) 1.88
ENHANCEMENT OF BACTERIAL ENDOTOXIN LETHALITY BY STAPHYLOCOCCAL ENTEROTOXIN. J Infect Dis (1964) 1.87
Binary and ternary complexes between T-cell receptor, class II MHC and superantigen in vitro. Nature (1994) 1.79
The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med (2010) 1.73
Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol (2001) 1.55
Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med (2007) 1.52
A cluster of ecthyma outbreaks caused by a single clone of invasive and highly infective Streptococcus pyogenes. Clin Infect Dis (2009) 1.51
Exanthematous disease induced by toxic shock syndrome toxin 1 in the early neonatal period. Lancet (1998) 1.49
Staphylococcal toxic shock syndrome erythroderma is associated with superantigenicity and hypersensitivity. Clin Infect Dis (2009) 1.47
Toxins as weapons of mass destruction. A comparison and contrast with biological-warfare and chemical-warfare agents. Clin Lab Med (2001) 1.46
Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol (2010) 1.42
D-galactosamine lethality model: scope and limitations. J Endotoxin Res (2004) 1.39
LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock. Am J Respir Crit Care Med (1999) 1.35
Mechanisms of crosstalk between TNF-induced NF-kappaB and JNK activation in hepatocytes. Biochem Pharmacol (2006) 1.33
Studies on the mechanism of galactosamine-1-phosphate and its inhibition of UDP-glucose pyrophosphorylase. Eur J Biochem (1969) 1.22
Evidence for the involvement of endotoxin in toxic shock syndrome. J Infect Dis (1987) 1.22
Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis (2002) 1.17
In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists. Infect Immun (2004) 1.11
Intranasal exposure to staphylococcal enterotoxin B elicits an acute systemic inflammatory response. Shock (2006) 1.10
Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice. J Infect Dis (2001) 1.07
Human leukocyte antigen-DQ8 transgenic mice: a model to examine the toxicity of aerosolized staphylococcal enterotoxin B. Infect Immun (2005) 1.06
Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M. Tissue Antigens (2003) 1.05
Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice. Infect Immun (2006) 1.05
Kawasaki disease: an overview. Curr Opin Infect Dis (2008) 1.04
Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics. Clin Infect Dis (2006) 1.04
Toxin-mediated streptococcal and staphylococcal disease. J Am Acad Dermatol (1998) 1.04
Understanding the mechanism of action of bacterial superantigens from a decade of research. Immunol Rev (1999) 1.02
Characterization of HLA DR2 and DQ8 transgenic mouse with a new engineered mouse class II deletion, which lacks all endogenous class II genes. J Autoimmun (2003) 1.00
Changes in murine jejunal morphology evoked by the bacterial superantigen Staphylococcus aureus enterotoxin B are mediated by CD4+ T cells. Infect Immun (1998) 1.00
Recognition and management of Staphylococcus aureus toxin-mediated disease. Intern Med J (2005) 0.99
CD4+ T cells mediate superantigen-induced abnormalities in murine jejunal ion transport. Am J Physiol (1998) 0.98
Toxic shock syndrome after functional endonasal sinus surgery: an all or none phenomenon? Laryngoscope (1994) 0.97
Increased susceptibility to staphylococcal enterotoxin B intoxication in mice primed with actinomycin D. Infect Immun (1994) 0.97
Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality. Hepatology (2005) 0.96
Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics. J Infect Dis (2002) 0.94
Staphylococcus aureus: An old pathogen with new weapons. Clin Lab Med (2010) 0.90
Systemic inflammation increases intestinal permeability during experimental human endotoxemia. Shock (2009) 0.90
Usefulness of antimicrobial resistance pattern for detecting PVL- or TSST-1-producing meticillin-resistant Staphylococcus aureus in a French university hospital. J Med Microbiol (2009) 0.89
Staphylococcal enterotoxin B-induced activation and concomitant resistance to cell death in CD28-deficient HLA-DQ8 transgenic mice. Int Immunol (2002) 0.88
Early gene expression changes induced by the bacterial superantigen staphylococcal enterotoxin B and its modulation by a proteasome inhibitor. Physiol Genomics (2009) 0.88
Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain. J Immunol (2002) 0.87
Metabolic studies in experimental liver disease resulting from D(+)-galactosamine administration. Biochem J (1972) 0.84
Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome. J Infect Dis (2003) 0.82
Reduced susceptibility of nonobese diabetic mice to TNF-alpha and D-galactosamine-mediated hepatocellular apoptosis and lethality. J Immunol (2000) 0.82
Characterization of three Staphylococcus aureus isolates from a 17-year-old female who died of tampon-related toxic shock syndrome. J Clin Microbiol (2010) 0.80
Staphylococcal toxic shock syndrome: still a problem. Med J Aust (2005) 0.80
Cyclooxygenase 2 pathway and its therapeutic inhibition in superantigen-induced toxic shock. Shock (2008) 0.79
Fatal toxic shock syndrome from an intrauterine device. Ann Emerg Med (2009) 0.76
Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med (2007) 7.82
Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol (2006) 5.78
Clinical practice. Infection associated with prosthetic joints. N Engl J Med (2009) 4.26
Synovial fluid leukocyte count and differential for the diagnosis of prosthetic knee infection. Am J Med (2004) 3.75
Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc (2012) 3.60
Microbiologic diagnosis of prosthetic shoulder infection by use of implant sonication. J Clin Microbiol (2009) 2.69
Drastic down-regulation of Krüppel-like factor 4 expression is critical in human gastric cancer development and progression. Cancer Res (2005) 2.67
Comparison of direct colony method versus extraction method for identification of gram-positive cocci by use of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 2.67
Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer (2005) 2.49
From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev (2008) 2.47
Comparison of Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometer to BD Phoenix automated microbiology system for identification of gram-negative bacilli. J Clin Microbiol (2011) 2.42
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol (2002) 2.35
Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma. Clin Cancer Res (2003) 2.28
Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol (2009) 2.26
Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation. Clin Infect Dis (2008) 2.12
Comparison of a novel, rapid chromogenic biochemical assay, the Carba NP test, with the modified Hodge test for detection of carbapenemase-producing Gram-negative bacilli. J Clin Microbiol (2013) 2.09
A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clin Infect Dis (2013) 2.08
The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer Cell (2012) 2.02
Prosthetic joint infection. Clin Microbiol Rev (2014) 1.97
Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol (2002) 1.96
Sonication of explanted prosthetic components in bags for diagnosis of prosthetic joint infection is associated with risk of contamination. J Clin Microbiol (2006) 1.93
New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum (2007) 1.92
Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med (2002) 1.92
Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol (2010) 1.88
Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009. N Engl J Med (2011) 1.84
Association between expression of transcription factor Sp1 and increased vascular endothelial growth factor expression, advanced stage, and poor survival in patients with resected gastric cancer. Clin Cancer Res (2004) 1.84
Establishment and characterization of a bona fide Barrett esophagus-associated adenocarcinoma cell line. Cancer Biol Ther (2008) 1.83
Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol (2003) 1.82
Identification of non-diphtheriae corynebacterium by use of matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2011) 1.82
Molecular and antibiofilm approaches to prosthetic joint infection. Clin Orthop Relat Res (2003) 1.82
Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Cancer (2007) 1.73
Multiplex LightCycler PCR assay for detection and differentiation of Bordetella pertussis and Bordetella parapertussis in nasopharyngeal specimens. J Clin Microbiol (2002) 1.72
Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture. J Clin Microbiol (2009) 1.69
Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res (2008) 1.64
Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology (2008) 1.63
Zygomycosis in solid organ transplant recipients: a prospective, matched case-control study to assess risks for disease and outcome. J Infect Dis (2009) 1.62
Prosthetic joint infection diagnosis using broad-range PCR of biofilms dislodged from knee and hip arthroplasty surfaces using sonication. J Clin Microbiol (2012) 1.62
Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol (2010) 1.58
Three-hour molecular detection of Campylobacter, Salmonella, Yersinia, and Shigella species in feces with accuracy as high as that of culture. J Clin Microbiol (2010) 1.58
Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg (2003) 1.56
Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol (2006) 1.55
Hedgehog: an attribute to tumor regrowth after chemoradiotherapy and a target to improve radiation response. Clin Cancer Res (2006) 1.52
Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma. Am J Surg Pathol (2007) 1.52
Rapid molecular microbiologic diagnosis of prosthetic joint infection. J Clin Microbiol (2013) 1.52
Leukocyte cell-derived chemotaxin 2 (LECT2)-associated amyloidosis is a frequent cause of hepatic amyloidosis in the United States. Blood (2014) 1.50
Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. Arch Pathol Lab Med (2008) 1.50
Vancomycin-resistant enterococci: colonization, infection, detection, and treatment. Mayo Clin Proc (2006) 1.48
Performance of flow cytometry to screen urine for bacteria and white blood cells prior to urine culture. Clin Biochem (2013) 1.47
Formic acid-based direct, on-plate testing of yeast and Corynebacterium species by Bruker Biotyper matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol (2012) 1.44
Intravenously administered pharmaceuticals impact biofilm formation and detachment of Staphylococcus lugdunensis and other staphylococci. Diagn Microbiol Infect Dis (2007) 1.43
Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol (2005) 1.43
Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One (2012) 1.42
Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis. J Antimicrob Chemother (2005) 1.41
Pretherapy nuclear factor-kappaB status, chemoradiation resistance, and metastatic progression in esophageal carcinoma. Mol Cancer Ther (2006) 1.41
Meningococcal meningitis with brainstem infarction. Arch Neurol (2007) 1.39
Prognostic significance of CpG island methylator phenotype and microsatellite instability in gastric carcinoma. Clin Cancer Res (2005) 1.38
In vitro effects of antimicrobial agents on planktonic and biofilm forms of Staphylococcus lugdunensis clinical isolates. Antimicrob Agents Chemother (2006) 1.37
Significance of the depth of tumor invasion and lymph node metastasis in superficially invasive (T1) esophageal adenocarcinoma. Am J Surg Pathol (2005) 1.36
"Seedling" mesenchymal tumors (gastrointestinal stromal tumors and leiomyomas) are common incidental tumors of the esophagogastric junction. Am J Surg Pathol (2007) 1.34
Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J Clin Microbiol (2008) 1.34
Association of activated transcription factor nuclear factor kappab with chemoradiation resistance and poor outcome in esophageal carcinoma. J Clin Oncol (2006) 1.33
Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study. Am J Gastroenterol (2011) 1.32
A humanized model of experimental autoimmune uveitis in HLA class II transgenic mice. J Clin Invest (2003) 1.32
Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation. J Clin Oncol (2005) 1.30
Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis (2006) 1.30
HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol (2002) 1.30
Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol (2009) 1.29
Comparison of three preparatory methods for detection of bacteremia by MALDI-TOF mass spectrometry. Diagn Microbiol Infect Dis (2012) 1.29
Importance of using Bruker's security-relevant library for Biotyper identification of Burkholderia pseudomallei, Brucella species, and Francisella tularensis. J Clin Microbiol (2013) 1.28
Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg (2013) 1.27
Genetic alterations in goblet cell carcinoids of the vermiform appendix and comparison with gastrointestinal carcinoid tumors. Mod Pathol (2003) 1.26
Evaluation of the Bruker Biotyper and Vitek MS matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of nonfermenting gram-negative bacilli isolated from cultures from cystic fibrosis patients. J Clin Microbiol (2012) 1.25
BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol (2005) 1.23
Gastric adenomas: intestinal-type and gastric-type adenomas differ in the risk of adenocarcinoma and presence of background mucosal pathology. Am J Surg Pathol (2002) 1.23
A biofilm approach to detect bacteria on removed spinal implants. Spine (Phila Pa 1976) (2010) 1.22
Possible overestimation of penicillin resistant Streptococcus pneumoniae colonization rates due to misidentification of oropharyngeal streptococci. Diagn Microbiol Infect Dis (2002) 1.22
Frequent CpG island methylation in precursor lesions and early gastric adenocarcinomas. Oncogene (2004) 1.22
IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis. Am J Surg Pathol (2010) 1.22
An evaluation of repeat stool testing for Clostridium difficile infection by polymerase chain reaction. J Clin Gastroenterol (2012) 1.21
Expression of annexin A1 in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Clin Cancer Res (2006) 1.21
C-reactive protein, erythrocyte sedimentation rate and orthopedic implant infection. PLoS One (2010) 1.20
Bacteremia due to viridans group Streptococci with diminished susceptibility to Levofloxacin among neutropenic patients receiving levofloxacin prophylaxis. Clin Infect Dis (2002) 1.20
HLA class II transgenic mice mimic human inflammatory diseases. Adv Immunol (2008) 1.18
The electricidal effect: reduction of Staphylococcus and pseudomonas biofilms by prolonged exposure to low-intensity electrical current. Antimicrob Agents Chemother (2008) 1.17
Effect of electrical current on the activities of antimicrobial agents against Pseudomonas aeruginosa, Staphylococcus aureus, and Staphylococcus epidermidis biofilms. Antimicrob Agents Chemother (2008) 1.17
Laboratory and clinical characteristics of Staphylococcus lugdunensis prosthetic joint infections. J Clin Microbiol (2010) 1.17
Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis (2002) 1.17
Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway. Mod Pathol (2002) 1.16
Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol (2007) 1.16
Isolation of Robinsoniella peoriensis from four human specimens. J Clin Microbiol (2010) 1.16
Mechanism by which HLA-DR4 regulates sex-bias of arthritis in humanized mice. J Autoimmun (2010) 1.16
Rapid and simultaneous detection of genes encoding Klebsiella pneumoniae carbapenemase (blaKPC) and New Delhi metallo-β-lactamase (blaNDM) in Gram-negative bacilli. J Clin Microbiol (2013) 1.16
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Reevaluation of Streptococcus bovis endocarditis cases from 1975 to 1985 by 16S ribosomal DNA sequence analysis. J Clin Microbiol (2002) 1.15
Corynebacterium prosthetic joint infection. J Clin Microbiol (2012) 1.15
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res (2008) 1.15
Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma. Neoplasia (2008) 1.15
Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum. J Clin Microbiol (2002) 1.15